CACNA1C and schizophrenia: MANOVAs showed significant main effects for CACNA1C rs2283274 (GG vs. CG/CC) (F(6,70) = 3.012, p = 0.011) and rs2239061 (AA vs. AG/GG) (F(6,70) = 2.235, p = 0.050) in schizophrenia patients, but not in healthy controls.